Menu
Science
Our Approach
Pipeline
About
Our Team
Team
The Board
Advisors
Investors
News
Contact Us
SITC 2020 POSTER
Immunopeptidome changes mediated by a novel ERAP1 inhibitor lead to tumour growth inhibition.
Register to receive a copy of Grey Wolf’s poster presented at SITC 2020.
Please leave this field empty.
* I consent to giving the above information to Grey Wolf Therapeutics. I am aware my details will be saved for contact and marketing purposes.
Cookies
This site uses cookies to improve site performance and offer advertising tailored to your interests.
Find out more.
Okay, thanks